Article
CMTM6, the newly identified PD-L1 regulator, correlates with PD-L1 expression in lung cancers
3 Oct 2019
Abstract excerpt
Modulation of Immune check point regulators, especially the PD-1/PD-L1 axis, plays a critical role in successful management of a small proportion of lung cancer patients, but not so effective in the rest of lung cancer patients. A better understanding of immunotherapy non-responsive or resistant patients therefore warranted for future development of novel therapeutics. The newly identified regulator CMTM6...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.